| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Ascher HL | |
| P2860 | cites work | HOMOTRANSPLANTATION OF THE LIVER IN HUMANS | Q24658552 |
| Analysis of donor criteria for the prediction of outcome in clinical liver transplantation | Q33993397 | ||
| OKT3 in the reversal of acute hepatic allograft rejection | Q33997759 | ||
| Experience with primary liver transplantation across ABO blood groups | Q34024639 | ||
| Successful liver transplantation from crossmatch-positive donors | Q34066517 | ||
| A multifactorial system for equitable selection of cadaver kidney recipients | Q34171541 | ||
| Biliary tract complications in human orthotopic liver transplantation | Q34187631 | ||
| Clinical presentation of hepatic artery thrombosis after liver transplantation in the cyclosporine era. | Q34187679 | ||
| Choosing a pediatric recipient for orthotopic liver transplantation | Q34240993 | ||
| Evolution of liver transplantation | Q34275840 | ||
| Prognostic value of preoperatively obtained clinical and laboratory data in predicting survival following orthotopic liver transplantation | Q34286956 | ||
| Influence of selected patient variables and operative blood loss on six-month survival following liver transplantation | Q34498280 | ||
| Transplantation for primary biliary cirrhosis | Q34985152 | ||
| Histopathology of serial graft biopsies from liver transplant recipients | Q35858014 | ||
| Treatment of fibrolamellar hepatoma with partial or total hepatectomy and transplantation of the liver. | Q37298376 | ||
| Orthotopic homotransplantation of the human liver | Q38540105 | ||
| Critical hypotheses on cyclosporine in bone marrow transplantation. | Q39649617 | ||
| The acquired immunodeficiency syndrome and transplantation | Q39660826 | ||
| Liver transplantation in the adult | Q39699957 | ||
| Liver transplantation today | Q39727490 | ||
| Fulminant and subfulminant liver failure: definitions and causes | Q39742321 | ||
| Biliary complications after liver transplantation: with special reference to the biliary cast syndrome and techniques of secondary duct repair | Q40747843 | ||
| Effects of the new anti-lymphocytic peptide cyclosporin A in animals | Q40788620 | ||
| Observations on Preservation, Bile Drainage and Rejection in 64 Human Orthotopic Liver Allografts | Q40795537 | ||
| The acute vanishing bile duct syndrome (acute irreversible rejection) after orthotopic liver transplantation | Q40797369 | ||
| Successful Chemoprophylaxis forPneumocystis cariniiPneumonitis | Q41342669 | ||
| Human orthotopic liver transplantation: surgical aspects in 393 consecutive grafts | Q41987265 | ||
| Cyclosporine metabolite concentrations in the blood of liver, heart, kidney, and bone marrow transplant patients | Q42399426 | ||
| Recurrent hepatitis B in liver allograft recipients. Differentiation between viral hepatitis B and rejection | Q42752143 | ||
| The first 100 liver transplants at UCLA. | Q44791634 | ||
| Use of a prognostic index in evaluation of liver transplantation for primary biliary cirrhosis | Q44824394 | ||
| Long-term immunoprophylaxis of hepatitis B virus reinfection in recipients of human liver allografts | Q45832546 | ||
| Blood transfusion requirements and renal function in patients undergoing liver transplantation without venous bypass | Q49135929 | ||
| Mechanism of action of washout solutions for kidney preservation | Q52729324 | ||
| Quadruple immunosuppressive therapy for liver transplantation | Q68129175 | ||
| Percutaneous transhepatic cholangiography rather than ultrasound as a screening test for postoperative biliary complications in liver transplant patients | Q68129213 | ||
| Interaction of erythromycin with cyclosporine | Q68135825 | ||
| Some further notes on venous bypass for orthotopic transplantation of the liver | Q68177177 | ||
| Glomerular hemodynamics and hormonal participation on cyclosporine nephrotoxicity | Q68183287 | ||
| Indication, technique, and results of liver graft volume reduction before orthotopic transplantation in children | Q68199437 | ||
| Successful intermittent chemoprophylaxis for Pneumocystis carinii pneumonitis | Q68821414 | ||
| Immunohistologic labeling as an indicator of liver allograft rejection | Q68925897 | ||
| Liver transplantation in older patients | Q68930410 | ||
| Extended preservation of the liver for clinical transplantation | Q69914534 | ||
| Liver transplantation for fulminant hepatic failure | Q69923933 | ||
| Organization of a new liver transplant center | Q69923941 | ||
| Incidence of cytomegalovirus infection and its relationship to donor-recipient serologic status in liver transplantation | Q70168121 | ||
| A clear distinction between "immune activation of rejection" and "no immune activation" in liver transplant aspiration cytology | Q70198932 | ||
| Can serum liver function tests differentiate rejection from other causes of liver dysfunction after hepatic transplantation? | Q70224385 | ||
| Liver transplantation for liver cancer | Q70243583 | ||
| A randomized clinical trial comparing OKT3 and steroids for treatment of hepatic allograft rejection | Q70318098 | ||
| Venous bypass in clinical liver transplantation | Q70386801 | ||
| Orthotopic liver transplantation: a pathological study of 63 serial liver biopsies from 17 patients with special reference to the diagnostic features and natural history of rejection | Q72401831 | ||
| Expression of HLA-DR antigens on bileduct cells of rejected liver transplant | Q72569997 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | liver transplantation | Q1368191 |
| P304 | page(s) | 316-321 | |
| P577 | publication date | 1988-09-01 | |
| P1433 | published in | Western Journal of Medicine | Q7476269 |
| P1476 | title | Liver transplantation--the first 25 years | |
| P478 | volume | 149 |
| Q28728002 | Donation after cardio-circulatory death liver transplantation | cites work | P2860 |
Search more.